HEPATIC ENCEPHALOPATHY
Clinical trials for HEPATIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for HEPATIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common gut drug reverse liver confusion?
Disease control CompletedThis study tested whether nifuroxazide, a gut antibiotic, can help reverse confusion caused by liver disease (hepatic encephalopathy) in 80 adults with cirrhosis. Participants had moderate to severe confusion and were treated to see if their mental status improved. The goal was t…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Cairo University • Aim: Disease control
Last updated May 26, 2026 04:20 UTC
-
New sleep aid shows promise for liver patients
Symptom relief CompletedThis study tested a sleep medication called lemborexant in 82 adults with liver cirrhosis who had trouble sleeping. The goal was to see if it could improve sleep quality safely. The drug works by blocking wakefulness signals in the brain to promote natural sleep.
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated May 26, 2026 04:17 UTC
-
Your voice may reveal hidden brain changes in liver disease
Knowledge-focused CompletedThis study looked at whether speech features (like tone, word choice, and sentence structure) can help detect early signs of confusion in people with cirrhosis. Researchers followed 251 participants over time, testing their thinking skills and recording their speech. The goal was…
Matched conditions: HEPATIC ENCEPHALOPATHY
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 26, 2026 04:14 UTC